Agilent Technologies

Agilent Technologies specializes in providing application-focused solutions within the life sciences, diagnostics, and applied chemical markets globally. The company operates through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers a variety of analytical instruments, including chromatography systems and mass spectrometry equipment, alongside laboratory automation and analytical software. The Diagnostics and Genomics segment focuses on advanced genetic analysis tools, including DNA mutation detection and gene expression profiling, as well as quality control solutions for nucleic acid samples. The Agilent CrossLab segment supplies laboratory consumables, custom chemistries, and a range of support services aimed at optimizing laboratory operations. With a strong customer base across biopharmaceutical, environmental, academic, and government sectors, Agilent Technologies emphasizes collaboration and innovation to address evolving scientific needs. Headquartered in Santa Clara, California, the company utilizes multiple sales channels, including direct sales and electronic commerce, to reach its diverse clientele.

Padraig McDonnell

CEO and President

77 past transactions

Halo Labs

Series C in 2022
Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics. Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.

Arima Genomics

Series B in 2022
Arima Genomics, Inc. is a biotechnology company based in San Diego, California, focused on advancing the understanding of genome sequence and structure in relation to human health, disease, and species evolution. The company develops innovative genomic solutions, including the Arima-HiC proximity ligation kit, which captures the three-dimensional organization of chromatin. This method allows for the identification of long-range genomic interactions, even when sequences are distally located in linear arrangements. Additionally, Arima offers the Arima-HiChIP protocol, which combines Hi-C techniques with chromatin immunoprecipitation to enrich for protein-mediated interactions. These tools facilitate various genomic applications, such as studying gene regulation through promoter-enhancer interactions and constructing genome assemblies. Incorporated in 2015, Arima Genomics aims to support scientific research by providing critical insights into genetic structures and their implications for health and disease.

Molecular Assemblies

Series B in 2022
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.

PreciseDx

Series A in 2022
PreciseDx is a company specializing in cancer risk stratification by providing patient-specific risk assessments through the analysis of morphological features. Utilizing artificial intelligence and its proprietary Morphology Feature Array™, PreciseDx develops disease-specific assays that offer detailed insights into each patient's risk profile and potential outcomes, thereby enhancing treatment decision-making. The company combines its clinical, regulatory, and translational research expertise to advance technologies in areas such as clinical modeling, patient phenotyping, and image analysis, ultimately aiming to improve patient outcomes and quality of life in the realm of cancer and other diseases.

Nicoya Lifesciences

Series A in 2021
Nicoya Lifesciences Inc. develops sensor products to get affinity, kinetics, and specificity for proteins, antibodies, DNA, RNA, enzymes, polymers, and small molecules. The company offers surface plasmon resonance (SPR) instruments, spectrophotometers, sensor chips, SPR reagents and kits, and SPR accessories; and OpenSPR, a personal label-free biomolecular analysis instrument. It also provides software solutions, such as TraceDrawer, a real-time kinetic analysis software; OpenSPR software that allows the control of the OpenSPR instrument and real time data acquisition; and OpenSpec, a software program for real time optical peak tracking. The company was founded in 2012 and is based in Kitchener, Canada.

Akadeum

Series B in 2021
Akadeum Life Sciences, Inc. is a life sciences company headquartered in Ann Arbor, Michigan, that specializes in manufacturing microbubble cell separation products. Founded in 2014, the company focuses on isolating mammalian and bacterial cells from complex mixtures, offering a range of products including T cell and B cell isolation kits for human and mouse cells. Additionally, Akadeum provides depletion microbubbles for red blood cell removal and streptavidin microbubbles for targeting and capturing various biological entities. Its innovative approach utilizes buoyancy-activated cell sorting, which employs microscopic microbubbles to effectively isolate target cells by floating them to the surface of liquid samples. These advancements enable medical practitioners to perform downstream testing and analysis with enhanced efficiency. The company sells its products online and has established a strategic partnership with Agilent Technologies.

RareCyte

Series G in 2021
RareCyte, Inc. is a life sciences company based in Seattle, Washington, that specializes in the development of liquid and tissue biopsy analysis platforms aimed at the detection of rare cells. Founded in 2009, RareCyte focuses on providing innovative technologies for the Life Sciences research, drug development, and diagnostic markets. The company offers a range of products, including sample preparation systems, staining kits, and automated fluorescence microscopy instruments. Its AccuCyte system is particularly notable for enabling the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. RareCyte's technologies are designed to address complex challenges in cancer and cardiovascular disease research, facilitating advancements in precision medicine and non-invasive prenatal testing.

MOBILion Systems

Series C in 2021
MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

Molecular Assemblies

Series A in 2021
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.

Resolution Bioscience

Acquisition in 2021
Resolution Bioscience is a healthcare research company specializes in NGS Technology, Molecular Biology, Cancer Diagnostics & more.

Cardea

Series A in 2020
Cardea Bio, Inc. is a biotechnology company based in San Diego, California, specializing in bioelectronics and graphene-based digital biosensor technology. Founded in 2013, the company develops products that facilitate precision healthcare by enhancing the ease, speed, and cost-effectiveness of diagnostics. Its key offerings include AGILE R100, an innovative assay for small molecule drug discovery, and AGILE R200, an automated high-throughput screening solution. Cardea's biosensors utilize biocompatible graphene to transform biological signals into digital data, enabling real-time analysis of biomolecules. This technology supports applications in small molecule validation, antibody characterization, and biomolecular analysis, serving the life sciences and healthcare sectors. The company also sells its products online, contributing to advancements in research and diagnostics.

MOBILion Systems

Series B in 2020
MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

DNA Script

Series B in 2020
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

Arima Genomics

Series A in 2020
Arima Genomics, Inc. is a biotechnology company based in San Diego, California, focused on advancing the understanding of genome sequence and structure in relation to human health, disease, and species evolution. The company develops innovative genomic solutions, including the Arima-HiC proximity ligation kit, which captures the three-dimensional organization of chromatin. This method allows for the identification of long-range genomic interactions, even when sequences are distally located in linear arrangements. Additionally, Arima offers the Arima-HiChIP protocol, which combines Hi-C techniques with chromatin immunoprecipitation to enrich for protein-mediated interactions. These tools facilitate various genomic applications, such as studying gene regulation through promoter-enhancer interactions and constructing genome assemblies. Incorporated in 2015, Arima Genomics aims to support scientific research by providing critical insights into genetic structures and their implications for health and disease.

MOBILion Systems

Series A in 2019
MOBILion Systems, Inc. is a biotechnology company focused on advancing the detection and analysis of clinically relevant molecules that conventional instruments struggle to identify. The company has developed structures for lossless ion manipulation (SLIM), which facilitate ion mobility separations and enable researchers to detect minute traces of disease-specific biomolecules. Founded in 2015 and based in Chadds Ford, Pennsylvania, MOBILion's technology enhances the sensitivity, resolution, and throughput of analytical instruments. This innovation supports the identification of biologic therapeutics, accelerates biomarker discovery, and improves the accuracy of diagnostic tests. By processing large-scale samples efficiently, MOBILion aims to contribute to better disease prediction, diagnosis, and treatment, ultimately empowering clinicians and researchers to address diseases at their core rather than merely treating symptoms.

Molecular Assemblies

Series A in 2019
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.

BioTek Instruments

Acquisition in 2019
BioTek Instruments, Inc. specializes in the development, manufacturing, and sale of life science instrumentation and software. The company offers a diverse range of products, including multi-mode microplate readers, imaging and microscopy systems, and liquid handling instruments such as microplate washers, dispensers, and pipetting systems. BioTek also provides automation solutions, including robotic microplate stackers, as well as data analysis software and accessories for laboratory applications. Its instruments support various fields, including healthcare, pharmaceuticals, agriculture, and research, facilitating cost-effective analysis and quantification of biomolecules and cellular functions. Headquartered in Winooski, Vermont, BioTek has a global presence with offices and support services in multiple countries, including Germany, China, and the United Kingdom. Founded in 1968, the company operates as a subsidiary of Agilent Technologies, Inc. since 2019.

Purigen Biosystems

Series B in 2019
Purigen Biosystems' innovative products offer a truly transformative solution for DNA and RNA purification. Our proprietary approach uses isotachophoresis to separate nucleic acids freely in solution without binding or stripping from a physical surface. Because of this, our technology is agnostic to nucleic acid size or sequence and delivers unbiased results ― even from the more challenging sample types like FFPE tissue or low cell counts. Our Ionic Purification System and Kits combine to provide researchers with a fast, efficient and effective alternative for automated nucleic acid purification.

Mission Bio

Series B in 2018
Mission Bio, Inc. specializes in tools for studying cellular heterogeneity in human health and life science research. The company utilizes microfluidic droplet technology to provide solutions for molecular analysis at the single-cell level. Its flagship product, the Tapestri Platform, is the first single-cell multi-omics platform, allowing for the simultaneous detection of genotype and phenotype from the same cell, which enhances the understanding of disease progression and treatment responses. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating targeted single-cell DNA custom panels, applicable in various fields including oncology, blood cancers, solid tumors, and genome editing validation. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.

ACEA BIO

Acquisition in 2018
ACEA Biosciences, Inc. is a biotechnology company based in San Diego, California, specializing in the development and commercialization of advanced microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. Founded in 2002, ACEA has pioneered real-time, label-free cell-based assay technology, marketed under the xCELLigence brand. Its product lineup includes the x-CELLigence System for various applications in biomedicine and pharmaceuticals, CIM systems for real-time monitoring of cell migration, and several RTCA instruments for cardiotoxicity testing and impedance measurement. The company serves a global customer base of over 800 clients and has contributed to more than 350 peer-reviewed publications. Additionally, ACEA has a Therapeutics Business Unit focusing on oncology drug discovery, leveraging its biosensor technology and a proprietary library of over one million compounds. Currently, ACEA has a program in phase II clinical trials in China, underlining its commitment to innovation in the research and healthcare sectors. The company operates manufacturing facilities in Hangzhou, China, and is a subsidiary of Agilent Technologies, Inc.

Ultra Scientific

Acquisition in 2018
Ultra Scientific is a leading global producer of certified reference materials and laboratory solutions, headquartered in North Kingstown, Rhode Island. The company specializes in manufacturing and supplying a comprehensive catalog of chemical standards, including organic and inorganic standards, calibration standards, and quality control check standards. Its products serve various sectors, including environmental, pharmaceutical, biotechnology, life sciences, molecular testing, food, forensics, chemicals, energy, academia, and government. Ultra Scientific is recognized for its rapid turnaround capabilities, enabling laboratories to efficiently meet their specific needs and maintain compliance with industry standards.

Genohm

Acquisition in 2018
Genohm SA is a developer of cloud-based software solutions focused on laboratory management, founded in 2002 and headquartered in Lausanne, Switzerland. The company specializes in software automation solutions that integrate Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), and order management. Genohm's SLims platform is designed to allow scientists to customize their digital data management systems according to individual laboratory workflows. The company's client base includes a diverse range of international organizations, such as biobanks, research and development laboratories, next-generation sequencing laboratories in universities and hospitals, and biotechnology companies. Since May 2018, Genohm has operated as a subsidiary of Agilent Technologies, Inc.

LaserGen

Acquisition in 2018
LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.
Advanced Analytical Technologies, Inc. specializes in the development, manufacturing, and marketing of high-throughput, fully-automated nucleic acid and genetic analysis systems. The company's products cater to both commercial and research needs across various sectors, including molecular diagnostics, pharmaceuticals, life sciences, agriculture, and biofuels. Notable offerings include the Fragment Analyzer for DNA and RNA quality control, the Zero Agarose Gel DNA Analyzer for automated DNA fragment analysis, Oligo PRO for the purity analysis of oligonucleotides, and pKa PRO for measuring acid dissociation constants. These instruments utilize capillary electrophoresis technology combined with fluorescence detection or UV absorbance to streamline complex genomics workflows. Advanced Analytical Technologies also provides installation, training, warranty, and technical support services through a network of distributors and support centers. Founded in 1997 and headquartered in Ames, Iowa, the company maintains a laboratory and sales office in Heidelberg, Germany, and operates as a subsidiary of Agilent Technologies, Inc.

Luxcel Biosciences Ltd.

Acquisition in 2018
Luxcel Biosciences Ltd., founded in 2002 and based in Cork, Ireland, specializes in porphyrin-based, phosphorescent oxygen-sensing probes and sensors. The company primarily serves the pharmaceutical, food safety, and packaging industries, providing a range of products including oxygen and pH sensors, as well as assays for mitochondrial function, metabolism, and toxicity. Notable offerings include the MitoXpress–Xtra assay for measuring oxygen consumption, the pH-Xtra assay for monitoring extracellular acidification, and the MitoXpress-Intra assay for assessing cell oxygenation. Luxcel also offers the OpTech system for non-invasive package integrity and shelf-life studies, alongside rapid microbial tests for bacterial detection. The company's tools are utilized in diverse applications such as cell analysis, hepatotoxicity, and food safety testing. Luxcel Biosciences sells its products directly and through authorized distributors, catering to pharmaceutical companies, processed food manufacturers, biotechnology firms, university labs, and research institutes.

NanoCellect Biomedical

Series B in 2017
NanoCellect Biomedical, Inc. develops innovative flow cytometry and cell sorting technology aimed at enhancing the capabilities of life science researchers in cellular analysis, molecular diagnostics, and personalized medicine. Founded in 2009 and based in San Diego, California, the company offers the WOLF Cell Sorter, which utilizes a closed fluid-path microfluidic cartridge to facilitate cell sorting while minimizing biohazard risks and shear stress commonly associated with traditional methods. By making flow cytometry more affordable and accessible, NanoCellect aims to support biomedical researchers in analyzing and isolating cells efficiently, thereby promoting significant advancements in drug discovery and diagnostics. The company's technology is designed to provide rapid, objective, and quantitative data on individual cells, empowering scientists to conduct essential research with greater ease and precision.

Agilent Raman Spectroscopy

Acquisition in 2017
Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.

Multiplicom

Acquisition in 2016
Multiplicom N.V., founded in 2010 and based in Niel, Belgium, specializes in developing molecular diagnostic test kits that facilitate the collection of genetic information for personalized treatment. The company offers a range of diagnostic assays across three main segments: human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiovascular disorders, such as various BRCA and HNPCC assays. In oncology, Multiplicom provides kits for molecular tumor pathology and cancer genetics, including several BRCA and somatic tests. For prenatal diagnostics, the company offers the Clarigo product to detect chromosome abnormalities. Multiplicom also operates an informatics facility in Gent, Belgium, and has an additional office in Lyon, France. As of January 2017, Multiplicom N.V. is a subsidiary of Agilent Technologies, Inc.

Molecular Assemblies

Seed Round in 2016
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.

iLab Solutions

Acquisition in 2016
iLab Solutions specializes in web-based management services tailored for academic research institutions, including universities, research hospitals, and independent institutes. The company boasts a diverse clientele, featuring notable NIH-funded organizations. iLab’s offerings encompass a suite of tools designed for laboratory management, which includes functionalities for service request management, sample management, equipment reservation, billing, invoicing, and reporting. The firm employs a scientific advisory team composed of principal investigators from prestigious institutions, ensuring that its services are informed by current research practices. The leadership team at iLab brings extensive experience from various sectors, enhancing the company’s capability to serve its clients. iLab maintains a strong focus on customer support and effective implementation, conducting all software development and user support internally to foster a responsive and stable partnership with its clients. With a track record of significant growth, iLab is positioned as a reliable resource for academic research management, ensuring that institutions can efficiently manage their laboratory operations.

LaserGen

Series B in 2016
LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.

Seahorse Bioscience

Acquisition in 2015
Seahorse Bioscience specializes in the development of analytical instruments, biomanufacturing systems, and consumable labware for biological research and drug discovery. The company's flagship products include the Seahorse Extracellular Flux (XF) analyzers, which enable scientists to non-invasively measure the metabolic activity of cells. These instruments provide valuable insights into various cellular processes, including basal oxygen consumption, glycolysis rates, ATP turnover, and respiratory capacity, facilitating research into mitochondrial dysfunction. Seahorse Bioscience serves a diverse clientele, including academic institutions, pharmaceutical and biotech companies, as well as OEM manufacturers of assay kits and laboratory instruments.

Cartagenia

Acquisition in 2015
Cartagenia specializes in providing software and services for clinical genetics and molecular pathology laboratories. The company offers a platform designed for the assessment and reporting of clinical genomics data derived from next-generation sequencing and microarrays. This platform facilitates the visualization, assessment, and reporting of genetic data in relation to patient information, enabling genetic labs and clinicians to conduct clinically relevant analyses efficiently. By improving the speed and quality of genetic interpretation and counseling, Cartagenia aims to enhance the overall experience for patients and caregivers.

Gradient Design Automation

Acquisition in 2014
Gradient Design Automation, Inc. specializes in electro-thermal analysis software that creates three-dimensional temperature maps for chips and system-in-packages (SiP). The company offers several products, including FireBolt, an electro-thermal simulator for digital integrated circuits, and CircuitFire and HeatWave, both simulators designed for analog and mixed-signal integrated circuits. These tools are essential for thermal analysis and validation at various design stages, such as floorplanning, place and route, and package integration. Gradient Design Automation primarily serves integrated circuit designers and semiconductor companies focused on digital and mixed-signal applications in the United States. Founded in 2003, the company is headquartered in Santa Clara, California.

Gen9

Private Equity Round in 2013
Gen9 is a privately held company based in Cambridge, Massachusetts, that specializes in next-generation gene synthesis technology. Founded in 2009 by leaders in synthetic biology, Gen9 focuses on automating the high-throughput production of DNA constructs, which enhances the efficiency, cost-effectiveness, and accuracy of DNA synthesis compared to traditional methods. The company aims to leverage its innovative technology to facilitate applications in various industries, including pharmaceuticals, biofuels, and enzyme production. By advancing synthetic biology, Gen9 strives to expand the global capacity for DNA content production, supporting a range of constructive applications.

Aurora SFC Systems

Acquisition in 2012
Aurora SFC Systems, Inc. develops and manufactures supercritical fluid chromatography (SFC) products for normal phase separation in laboratory environments in the United States and internationally. The company offers Agilent 1260 Infinity Analytical SFC system, a modular system that consists of the Agilent 1260 Analytical SFC LC and the Aurora SFC Fusion A5 Evolution for pre- and post- conditioning of carbon dioxide.

Dako

Acquisition in 2012
Dako Denmark A/S specializes in providing reagents, instruments, and software for cancer diagnostics, primarily serving hospital and research laboratories globally. The company offers a wide range of pathology products, including antibodies, pharmacodiagnostic kits, and specialized staining instruments. These tools are essential for pathologists conducting in vitro diagnostics to identify cancer and other chronic diseases through tissue samples. Additionally, Dako produces flow cytometry products, which assist in analyzing cells in blood and other fluids for diagnosing conditions such as leukemia and lymphoma. The company also develops antibodies used to measure protein concentrations in various bodily fluids. Established in 1966 and headquartered in Glostrup, Denmark, Dako has formed collaborations with companies like Genentech and Roche for the clinical development of diagnostic tests. In 2012, Dako was acquired by Agilent Technologies.

Halo Genomics

Acquisition in 2011
A description for Halo Genomics is coming soon.

BioSystem Development

Acquisition in 2011
BioSystem Development specializes in creating, manufacturing, and marketing system products aimed at addressing unmet needs in biotechnology and life science research. The company's innovative offerings include cartridges filled with small polymer beads, which facilitate rapid protein analysis for drug developers. By focusing on these specific applications, BioSystem Development supports advancements in research and enhances the efficiency of biotechnological processes.

Accelicon Technologies

Acquisition in 2011
Accelicon Technologies is a privately held company specializing in device-level modeling and validation software for the electronics industry. The firm offers a SPICE model analysis solution aimed at ensuring model quality assurance. Its Model Quality Assurance (MQA) solution serves as a verification platform that facilitates communication between fabrication and design teams by comparing, documenting, and validating models provided by foundries. Additionally, Accelicon provides a modeling platform known as the Model Builder Platform (MBP), which enables modeling engineers to optimize the SPICE model library, aligning it closely with silicon data and specific design requirements. The company is focused on enhancing the accuracy and reliability of electronic circuit design through its innovative software offerings.

Lab901

Acquisition in 2011
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.

Biocius Life Sciences

Acquisition in 2011
Biocius Life Sciences, Inc. is a company specializing in drug discovery research, established in 2009 and located in Woburn, Massachusetts. As a subsidiary of BioTrove, Inc., Biocius develops advanced technologies, including high-throughput mass spectrometry systems, to facilitate the drug discovery process. The company's innovative approach aims to enhance efficiency and accuracy in identifying potential therapeutic compounds, contributing to advancements in pharmaceutical research and development.

Novelx

Acquisition in 2010
Novelx, incorporated in 2002 and based in Lafayette, California, specializes in the manufacture of low-cost, high-resolution electron beam columns. These columns utilize miniaturized modular scanning electron microscope technology, catering to various sectors including commercial, inspection, analysis, lithography, and military applications. The company focuses on providing advanced electron beam solutions that enhance precision and efficiency in their respective fields.

Varian

Acquisition in 2009
Varian, Inc. is a prominent global supplier of scientific instruments and vacuum technologies, primarily serving life science and industrial sectors. The company offers a comprehensive range of products and services, including instruments, vacuum products, laboratory consumables, software, and training, supported by its extensive distribution networks. With a workforce of approximately 3,900 employees, Varian operates manufacturing facilities across North America, Europe, and the Asia Pacific region. The company's commitment to providing integrated solutions has positioned it as a key player in the scientific and industrial markets.

MTS Nano Instruments

Acquisition in 2008
MTS Nano Instruments, Inc. develops and supplies equipment and software to determine the mechanical behavior of nano-scale materials and structures. Its products include nano-indentation systems, nanomechanical testing systems, and quantitative imaging systems. The company's products also include TestWorks Professional, a nanomechanical testing software; TestWorks Explorer, which enables users to define control channels, as well as design test methods; TestWorks 3D that automates scanning processes; Virtual Indenter, an analysis tool, which enables users to setup, execute, and analyze finite-element simulations of the indentation experiments; and Analyst, a data analysis assistant. In addition, it offers contract and educational services. The company's products are used for verifying the structural integrity of semiconductor devices, coatings, and thin films. It serves academic and industrial researchers involved in the areas of materials sciences, semiconductor, and life sciences. MTS Nano Instruments, Inc. was formerly known as Nano Instruments, Inc. The company was incorporated in 1983 and is based in Oak Ridge, Tennessee. As of June 27, 2008, MTS Nano Instruments, Inc. operates as a subsidiary of Agilent Technologies, Inc.

RVM Scientific

Acquisition in 2008
RVM Scientific, Inc. manufactures direct heating/cooling systems for gas chromatography capillary columns. The company’s products include low thermal mass retrofits and thermal desorber tubes. It also offers custom gas chromatography modules, which are used for low power consumption applications for portable instruments; high speed separations that use short narrow-bore columns; and column modules with metal columns that are used for high temperature applications.

Escort Instruments

Acquisition in 2008
Escort Instruments Corporation manufactures test and measurement instruments. The company focuses on offering general purpose test instruments, process test tools, and automotive diagnosis tools. Escort Instruments provides its products through a network of distributors worldwide.

TILL Photonics

Acquisition in 2008
TILL provides extremely flexible, modular systems for all current and future microscopy standards – and complete turnkey solutions for imaging and photometry systems. The majority of TILL’s customers are found in the fields of neurobiology, cell biology, biomedicine and pharmacology. The company’s headquarters are located in the Munich BioRegio (Germany), TILL Photonics’ US operation is based in Rochester, NY

Velocity11

Acquisition in 2007
Velocity11 is a life sciences technology company that specializes in designing and manufacturing automation solutions for researchers in the life sciences field. Founded in 1999 by Travis Chow and headquartered in the United States, the company offers a range of instruments, including liquid handling and microplate management products. One of its key offerings is BioCel, a versatile sample processing system that facilitates the assembly of genomics reactions, sample dispensing for compound preparation, and the processing of biological samples in various screening applications. Velocity11 focuses on automation services specifically tailored to drug discovery, genomics, and proteomics, effectively supporting researchers in their scientific endeavors.

Kalabie

Acquisition in 2007
Kalabie is an Electronic Lab Notebook (ELN) software vendor. Born in 2000, Kalabie was one of the few companies that position itself in the Pharma/Medicinal Chemistry market that later became the beach-head market for growth of the ELN category. Kalabie was funded by the Klee Group, an IT-services and software company based in France and with operations in Europe. Kalabie won a number of clients in Europe and particularly built a strong presence in Sanofi-Aventis. From 2004, the company experienced a steady growth and increased its worldwide presence and reinforced its status as one of the leading solution in this market. The ELN opportunity was rapidly seen by larger Software Vendors and Lab Equipment Manufacturer as a strategic offering in their portfolio and Kalabie was acquired by Agilent Technologies Inc. in 2007.

Stratagene

Acquisition in 2007
Stratagene Corporation develops, manufactures, and markets life science research products in the United States and internationally. The company supports advances in science by inventing, manufacturing, and distributing products that simplify, accelerate, and improve research. Its products are used in the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.

PXIT

Acquisition in 2006
PXIT, Inc. develops and manufactures test and measurement systems, primarily for use in high-speed data communications. It also offers signal integrity testing solutions for broadband electro-optical signals. The company’s products include digital communications analyser, bit error rate tester, pattern generator, and synthesizer. It offers its products to telecommunications, data communications, and lighting markets.

Acqiris

Acquisition in 2006
Acqiris SA, a privately held company that provides high-speed digitizers and analyzers used in commercial, industrial and government electronics markets.

Xpedion Design Systems

Acquisition in 2006
Xpedion Design Systems, Inc. provides transistor-level simulation, analysis, and behavioral modeling solutions to radio frequency integrated circuit or wireless and system-on-chip designers.

SynPro

Acquisition in 2006
SynPro Corp. manufactures short synthetic DNA and RNA molecules for the pharmaceutical and biotech industries. Its products are used as components of drugs in clinical trials. It makes synthetic nucleic acids used in biotech research.

Molecular Imaging Corp.

Acquisition in 2005
Molecular Imaging Corp. specializes in the development and manufacturing of nanotechnology measurement tools. The company produces a range of instruments, including Scanning Probe Microscopy and Atomic Force Microscopy systems, along with their associated accessories, software, and data management solutions. These tools are designed for imaging under controlled temperature and environmental conditions, making them suitable for various research applications. Molecular Imaging Corp. focuses on areas such as life science, biotechnology, electrochemistry, and material and polymer science. By providing advanced nanotechnology measurement solutions, the company enables customers to explore new application areas in both academic and industrial research settings.

Computational Biology

Acquisition in 2005
Computational Biology Corp. develops microarray-based techniques for understanding gene regulation in disease. The company utilizes ChIP-on-chip technology, which uses chromatin immuno-precipitation (ChIP) to discover how regulatory proteins interact with the genome of living cells.

Silicon Genetics

Acquisition in 2004
Silicon Genetics provides data analysis and management solutions focusing on molecular biology, statistics, and IT. The company’s products include GeneSpring, a visualization and analysis solution for genomic expression data on the desktop; Varia, which is genetic analysis software for life science researchers; and GeNet, provides scalable repository for expression data.

Sirific Wireless

Series B in 2004
Sirific Wireless is a semiconductor company specializing in the design and development of CMOS RF transceivers for the wireless communications market. Founded in 2000, the company is headquartered in Richardson, Texas, with additional offices in Waterloo, Canada, and Seoul, Korea. Sirific Wireless offers a range of products, including monolithic multi-mode wireless designs, digital direct conversion products, and Harmony-direct upconversion transmitters. Its NEXUS platform integrates multiple wireless standards such as HSDPA, WCDMA, EDGE, GPRS, and GSM, providing on-chip receive diversity for transceivers suitable for multi-mode and multi-band wireless applications.

TelASIC Communications

Series C in 2003
TelASIC Communications, Inc. develops remote radio head products for WCDMA/HSDPA and WiMAX/LTE infrastructure applications. The company's products enable the transmission of high output power to deliver high data rates and coverage for mobile TV/video/audio/data-centric 3G data services. TelASIC Communications, Inc. was founded in 2001 and is based in El Segundo, California.

RedSwitch

Acquisition in 2002
RedSwitch is a supplier of high performance switch fabric silicon solutions for the storage, server, networking, and telecom markets. Incorporated in June 2000 with headquarters in Milpitas, Calif., the company was formed by senior executives and design professionals from HAL Computer Systems Inc. RedSwitch products support leading interconnect standards including InfiniBand(TM), RapidIO (TM), and PCI-Express(TM).

SAN Valley Systems

Series C in 2002
SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.

Qosnetics

Acquisition in 2002
Qosnetics develops IP-based conformance verification and performance-stressing tools.

Tropian

Series D in 2001
Tropian, Inc. specializes in the development and provision of multimode radio frequency integrated circuits and solutions tailored for wireless devices. The company offers a range of products, including the Timestar radio frequency integrated circuit solutions designed for quad-band cellular handsets, as well as Codestar and Multistar radio transceivers. Tropian primarily serves manufacturers of wireless devices, delivering innovative technology to enhance communication capabilities. Formerly known as Premier R.F., Inc., the company has established itself as a key player in the wireless communications industry.

Wavefront Research

Acquisition in 2001
Wavefront Research, Inc. develops optical systems and technologies that solve problems evading conventional solutions. Its technologies include low-loss 1xN and MxN optical switches, compact optical time delay systems, dense alignment-tolerant intra-board VCSEL-based optical interconnects, dense alignment-tolerant board-to-board VCSEL-based optical interconnects, and ultra-lightweight and compact hyperspectral imagers.

Novera Optics

Venture Round in 2001
Novera Optics develops optical access solutions. Its PON optical solutions enable equipment vendors and service providers to address fiber-to-the-building, fiber-to-the-curb extensions, multi-dwelling and multi-tenant units, remote terminals, and the central office markets. The company offers Wavelength Division Multiplexed-Passive Optical Networks (WDM-PON), an access and transport platform, which provides an architecture for access networks that enables service providers to deliver voice, data, video, and wireless services.
Agilent's Interoperability Certification Labs, Inc. provides third party product testing services. It specializes in test and analysis services, such as performance; benchmarking; interoperability; and functional, certification, and conformance testing. The company offers its services to original equipment manufacturers, systems integrators, and industry groups.

MV Technology

Acquisition in 2001
MV Technology Ltd. provides automated optical-inspection systems and solutions for the electronics-manufacturing market.

ATN Microwave

Acquisition in 2000
ATN Microwave provided microwave measurement solutions for wireless and high speed data communications applications

Objective Systems Integrators

Acquisition in 2000
Objective Systems Integrators (OSI) is a global provider of Operations Support Systems (OSS) solutions designed for communications service providers. Since its establishment in 1989, OSI has focused on delivering innovative technology solutions, with its flagship NetExpert® platform offering visibility and service assurance for major service providers worldwide, including those involved in next-generation services like LTE. The NetExpert® platform enables communications service providers, including fixed, broadband, and wireless companies, to efficiently manage their networks, services, products, and customer interactions. It delivers comprehensive service, performance, and fault management for complex networks, allowing operators to monitor service quality at both aggregate and customer levels. OSI's expertise extends to systems integration, software development, and IT consulting services, helping organizations optimize technology investments and achieve their strategic goals through effective integration and support.

Entridia

Series C in 2000
Entridia Corporation is an Internet infrastructure company focused on developing advanced silicon-based routing engines that facilitate the convergence of data, voice, and video communications over the Internet. By providing innovative silicon and system solutions, Entridia aims to empower original equipment manufacturers (OEMs) in building the next generation of Internet gateways. Their products are designed to enhance network performance, ensuring reliable and efficient communication for users across various platforms.

SAN Valley Systems

Series B in 2000
SAN Valley is a privately held Silicon Valley company whose mission is to deliver high reliability, cost effective, next generation storage infrastructure solutions to enterprise and service providers worldwide. SAN Valley is developing high performance end-to-end optical edge access products to address the multi-billion dollar market opportunity for delivering value-added storage connectivity into enterprise, service provider and carrier networks.

Zymed

Acquisition in 2000
Zymed, Inc. develops and markets inpatient telemetry systems, cardiac analysis software algorithms, and outpatient holter and cardiac event monitoring systems. It serves diagnostic monitoring markets, which include holter, telemetry, event recorder, home cardiac monitoring, intensive/coronary care units, prevention analysis, interventional cardiology, and arrhythmia and ischemia disease management.

SAFCO

Acquisition in 2000
SAFCO Technologies, Inc. designs and develops radio frequency (RF) field measurement tools and analysis software for wireless applications.

American Holographic

Acquisition in 2000
American Holographic Inc specializes in the design and manufacture of holographic diffraction gratings and spectral sensor modules. Its products are utilized in a variety of sectors, including fiber optic communications, optical test equipment, pulse compression, and spectrographs. The company serves diverse industrial, research, and scientific applications, providing essential components that enhance the functionality and performance of optical systems.

J&W Scientific

Acquisition in 2000
J&W Scientific, Inc. manufactures scientific instruments such as high resolution gas chromatography columns, flowmeters, syringes, and gas flow and control instruments. The company produces Unimetrics Syringes, Humonics Flowmeters and R&D Separations Gas Filters.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.